Back to Search Start Over

Patient Management After Noninvasive Cardiac Imaging

Authors :
Stuart Rabinowitz
Joao A.C. Lima
Suhny Abbara
Richard C. Brunken
Matthew J. Budoff
Udo Hoffmann
Jon Hainer
Rob S. Beanlands
Randall Patterson
Marcelo F. Di Carli
Susan Farkas
Josef Machac
Leslee J. Shaw
James R. Johnson
Panithaya Chareonthaitawee
Adam E. Schussheim
Carolyn R. Corn
Gary V. Heller
Jill E. Jacobs
Richard D. White
Dominique Delbeke
Rory Hachamovitch
Elizabeth Branscomb
Benjamin Nutter
Ella A. Kazerooni
Kim A. Williams
John R. Lesser
Louise Thomson
W. Guy Weigold
Szilard Voros
Mariya Gaber
Benjamin J.W. Chow
Subha V. Raman
Steven R. Sigman
Erminia M. Guarneri
James R. Corbett
James A. Arrighi
Nathaniel Reichek
Courtney Foster
Uwe Joseph Schoepf
Daniel S. Berman
John W. Millstine
Mark A. Hlatky
James H. Caldwell
Sharmila Dorbala
Barbara Johnson
Tsunehiro Yasuda
Salvador Borges-Neto
Sabahat Bokhari
Julie A. Williams
Michael L. Ridner
Source :
Journal of the American College of Cardiology. 59:462-474
Publication Year :
2012
Publisher :
Elsevier BV, 2012.

Abstract

Objectives This study examined short-term cardiac catheterization rates and medication changes after cardiac imaging. Background Noninvasive cardiac imaging is widely used in coronary artery disease, but its effects on subsequent patient management are unclear. Methods We assessed the 90-day post-test rates of catheterization and medication changes in a prospective registry of 1,703 patients without a documented history of coronary artery disease and an intermediate to high likelihood of coronary artery disease undergoing cardiac single-photon emission computed tomography, positron emission tomography, or 64-slice coronary computed tomography angiography. Results Baseline medication use was relatively infrequent. At 90 days, 9.6% of patients underwent catheterization. The rates of catheterization and medication changes increased in proportion to test abnormality findings. Among patients with the most severe test result findings, 38% to 61% were not referred to catheterization, 20% to 30% were not receiving aspirin, 35% to 44% were not receiving a beta-blocker, and 20% to 25% were not receiving a lipid-lowering agent at 90 days after the index test. Risk-adjusted analyses revealed that compared with stress single-photon emission computed tomography or positron emission tomography, changes in aspirin and lipid-lowering agent use was greater after computed tomography angiography, as was the 90-day catheterization referral rate in the setting of normal/nonobstructive and mildly abnormal test results. Conclusions Overall, noninvasive testing had only a modest impact on clinical management of patients referred for clinical testing. Although post-imaging use of cardiac catheterization and medical therapy increased in proportion to the degree of abnormality findings, the frequency of catheterization and medication change suggests possible undertreatment of higher risk patients. Patients were more likely to undergo cardiac catheterization after computed tomography angiography than after single-photon emission computed tomography or positron emission tomography after normal/nonobstructive and mildly abnormal study findings. (Study of Perfusion and Anatomy9s Role in Coronary Artery [CAD] [SPARC]; NCT00321399)

Details

ISSN :
07351097
Volume :
59
Database :
OpenAIRE
Journal :
Journal of the American College of Cardiology
Accession number :
edsair.doi.dedup.....e006225baa7075d8b782a41ba28c1a10